Maud Brandely
Chief Tech/Sci/R&D Officer at TRANSGENE
Profile
Maud Brandely is currently working as the Chief Medical Officer & VP-Medical Affairs at Transgene SA since 2016.
Prior to this, Dr. Brandely worked as the Director-Oncology Clinical Development at Pierre Fabre SA and as the Director-Taxotere Clinical Development at Rhone-Poulenc SA. Dr. Brandely holds graduate and doctorate degrees from Université Pierre et Marie Curie.
Maud Brandely active positions
| Companies | Position | Start |
|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 17/03/2016 |
Former positions of Maud Brandely
| Companies | Position | End |
|---|---|---|
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/02/2016 |
| Rhone-Poulenc SA | Corporate Officer/Principal | - |
Training of Maud Brandely
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private companies | 3 |
|---|---|
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
| Rhone-Poulenc SA | Process Industries |
| Université Pierre et Marie Curie | Consumer Services |
- Stock Market
- Insiders
- Maud Brandely
